{"id":815829,"date":"2025-02-20T16:07:36","date_gmt":"2025-02-20T21:07:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/"},"modified":"2025-02-20T16:07:36","modified_gmt":"2025-02-20T21:07:36","slug":"kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/","title":{"rendered":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025"},"content":{"rendered":"
\n

LONDON, Feb. 20, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc<\/a> (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 25, 2025 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2024 financial results and recent portfolio execution.<\/p>\n

A live webcast will be accessible through the Investors & Media section of the company\u2019s website at www.kiniksa.com<\/a>. Individuals interested in participating in the call via telephone may register here<\/a>. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa\u2019s website within approximately 48 hours after the event.<\/p>\n

\n About Kiniksa<\/strong>
\n
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa\u2019s portfolio assets are based on strong biologic rationale or validated mechanisms and offer the potential for differentiation. For more information, please visit www.kiniksa.com<\/a>.<\/p>\n

\n
\n Every Second Counts!<\/em>
\n <\/strong>
\n
\n
\n \u00ae<\/em>
\n <\/strong>
\n <\/sup>\n <\/p>\n

\n Kiniksa Investor Contact<\/strong>
\n
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com<\/a><\/p>\n

\n Kiniksa Media Contact<\/strong>
\n
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON, Feb. 20, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 25, 2025 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company\u2019s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of … <\/p>\n

Continue reading “Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815829","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nKiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON, Feb. 20, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 25, 2025 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company\u2019s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of … Continue reading "Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T21:07:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025\",\"datePublished\":\"2025-02-20T21:07:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/\"},\"wordCount\":232,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/\",\"name\":\"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=\",\"datePublished\":\"2025-02-20T21:07:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/","og_locale":"en_US","og_type":"article","og_title":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk","og_description":"LONDON, Feb. 20, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 25, 2025 at 8:30 a.m. Eastern Time to report its fourth quarter and full year 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company\u2019s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of … Continue reading \"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T21:07:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025","datePublished":"2025-02-20T21:07:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/"},"wordCount":232,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/","name":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=","datePublished":"2025-02-20T21:07:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjEzOSM2NzYxMTM1IzIwOTc3ODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-february-25-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February\u00a025, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815829"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815829\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}